CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
暂无分享,去创建一个
D. Moher | D. Altman | P. Gøtzsche | M. Egger | K. Schulz | D. Elbourne | V. Montori | S. Hopewell | P. Devereaux
[1] T. Lang. Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate. , 2000, MedGenMed : Medscape general medicine.
[2] D. Moher,et al. CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration , 2008, PLoS medicine.
[3] T. Kaptchuk,et al. Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine , 1998, Bulletin of the history of medicine.
[4] A. Michalsen,et al. Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity , 2006, BMC medical research methodology.
[5] J. Noseworthy,et al. The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial , 1994, Neurology.
[6] S Greenland,et al. Randomization, Statistics, and Causal Inference , 1990, Epidemiology.
[7] P. Bath,et al. Quality of full and final publications reporting acute stroke trials: a systematic review. , 1998, Stroke.
[8] G H Guyatt,et al. Effect of encouragement on walking test performance. , 1984, Thorax.
[9] Nicholas C. Ide,et al. Issues in the registration of clinical trials. , 2007, JAMA.
[10] J. Stoner. Cross-over Trials in Clinical Research , 2004 .
[11] F. Davidoff,et al. Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper. , 1998, JAMA.
[12] A D Oxman,et al. Randomisation to protect against selection bias in healthcare trials. , 2011, The Cochrane database of systematic reviews.
[13] N L Geller,et al. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. , 1987, Biometrics.
[14] R. Greenblatt,et al. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols , 2005, AIDS.
[15] J. Hofland,et al. Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial , 2009, Trials.
[16] Douglas G. Altman,et al. RANDOMISATION : ESSENTIAL FOR REDUCING BIAS , 1991 .
[17] D. Rennie. Reporting randomized controlled trials. An experiment and a call for responses from readers. , 1995, JAMA.
[18] S. Goodman. Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy , 1999, Annals of Internal Medicine.
[19] K. Schulz,et al. Sample size calculations in randomised trials: mandatory and mystical , 2005, The Lancet.
[20] D. DeMets,et al. The randomized clinical trial: bias in analysis. , 1981, Circulation.
[21] M. Tramèr,et al. Impact of covert duplicate publication on meta-analysis: a case study , 1997, BMJ.
[22] J M Lachin,et al. Statistical considerations in the intent-to-treat principle. , 2000, Controlled clinical trials.
[23] K. Ah-See,et al. A qualitative assessment of randomized controlled trials in otolaryngology , 1998, The Journal of Laryngology & Otology.
[24] B. Demichelis,et al. Completeness of reporting trial results: effect on physicians' willingness to prescribe , 1994, The Lancet.
[25] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.
[26] J. Wittes,et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.
[27] M. Martínez-González,et al. Intention to treat analysis is related to methodological quality , 2000, BMJ : British Medical Journal.
[28] L. Kjaergard,et al. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ , 2002, BMJ : British Medical Journal.
[29] J. Concato,et al. The Risk of Determining Risk with Multivariable Models , 1993, Annals of Internal Medicine.
[30] D. Altman,et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research , 2004, Canadian Medical Association Journal.
[31] D. Streiner. Missing data and the trouble with LOCF , 2008, Evidence-based mental health.
[32] Quoting intermediate analyses can only mislead , 1997, BMJ.
[33] D. Rennie,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.
[34] S. Evans,et al. Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet , 2008, The Lancet.
[35] D. Sackett,et al. Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.
[36] K. Schulz,et al. Subverting randomization in controlled trials. , 1995, JAMA.
[37] D. Moher,et al. Statistical power, sample size, and their reporting in randomized controlled trials. , 1994, JAMA.
[38] Steven Reid. A different look , 2008 .
[39] D. Machin,et al. Intention to treat--who should use ITT? , 1993, British Journal of Cancer.
[40] Alex H S Harris,et al. The Accuracy of Abstracts in Psychology Journals , 2002, The Journal of psychology.
[41] D. Berry,et al. Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.
[42] D G Altman,et al. Statistics in medical journals. , 1982, Statistics in medicine.
[43] D. Moher,et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. , 2008, Annals of internal medicine.
[44] R. Horton,et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. , 2005, The Medical journal of Australia.
[45] R Peto,et al. Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.
[46] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[47] S M Gore,et al. Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976. , 1977, British medical journal.
[48] P. Lane. Handling drop‐out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches , 2008, Pharmaceutical statistics.
[49] O. Hjalmarson,et al. Early versus delayed neonatal administration of a synthetic surfactant: the judgment of Osiris , 1992 .
[50] Amir Herman,et al. Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials. , 2009, Journal of Bone and Joint Surgery. American volume.
[51] Harlan M Krumholz,et al. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. , 2008, JAMA.
[52] Douglas G Altman,et al. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols , 2008, BMJ : British Medical Journal.
[53] B. Beermann,et al. Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications , 2003, BMJ : British Medical Journal.
[54] J. Ware,et al. Interpreting incomplete data in studies of diet and weight loss. , 2003, The New England journal of medicine.
[55] Satish Iyengar,et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. , 2009, JAMA.
[56] I. Chalmers,et al. The Landscape and Lexicon of Blinding in Randomized Trials , 2002, Annals of Internal Medicine.
[57] D. Spiegelhalter,et al. Issues in data monitoring and interim analysis of trials. , 2005, Health technology assessment.
[58] I. Chalmers. From optimism to disillusion about commitment to transparency in the medico-industrial complex. , 2006, Journal of the Royal Society of Medicine.
[59] M. Smithson. Statistics with confidence , 2000 .
[60] R. J. Hayes,et al. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology , 1996, BMJ.
[61] G. Yamey,et al. The Impact of Open Access upon Public Health , 2006, PLoS Medicine.
[62] David L Streiner,et al. The Case of the Missing Data: Methods of Dealing with Dropouts and other Research Vagaries , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[63] J Savulescu,et al. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability , 1996, BMJ.
[64] Donald A Williamson,et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. , 2009, The New England journal of medicine.
[65] D G Altman,et al. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons , 1995, BMJ.
[66] R. Holubkov,et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. , 2007, JAMA.
[67] Douglas G Altman,et al. How to randomise , 1999, BMJ.
[68] Nilay D Shah,et al. Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. , 2008, Mayo Clinic proceedings.
[69] E. Antman,et al. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial , 2009, The Lancet.
[70] W. S. Fields,et al. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. , 1970 .
[71] Douglas G Altman,et al. Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.
[72] P Middleton,et al. Technical editing of research reports in biomedical journals. , 2007, The Cochrane database of systematic reviews.
[73] Salim Yusuf,et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[74] T R Einarson,et al. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[75] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[76] S Greenland,et al. Principles of multilevel modelling. , 2000, International journal of epidemiology.
[77] Denis Xavier,et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.
[78] Carl Heneghan,et al. What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.
[79] C. Ko,et al. Reporting Randomized, Controlled Trials , 2002, Diseases of the colon and rectum.
[80] G H Guyatt,et al. A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.
[81] Douglas G Altman,et al. Statistics Notes: Units of analysis , 1997, BMJ.
[82] Curtis L. Meinert,et al. A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. , 1994, JAMA.
[83] D. Moher,et al. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' , 2008, Trials.
[84] S. Schor,et al. Statistical evaluation of medical journal manuscripts. , 1966, JAMA.
[85] E. Franssen. How to Report Statistics in Medicine , 2008, Nature Medicine.
[86] F. Song,et al. Evaluating non-randomised intervention studies. , 2003, Health technology assessment.
[87] Douglas G. Altman,et al. Explanation and Elaboration , 2022 .
[88] R. Temple,et al. FDA perspective on trials with interim efficacy evaluations , 2006, Statistics in medicine.
[89] Joan Webster,et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial , 2008, BMJ : British Medical Journal.
[90] S. Goodman,et al. The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.
[91] D. Juurlink,et al. The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903] , 2003, BMC clinical pharmacology.
[92] C. Ramsay,et al. Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial , 2008, BMJ : British Medical Journal.
[93] B. Muthén,et al. Adaptive designs for randomized trials in public health. , 2009, Annual review of public health.
[94] H. Dargie,et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.
[95] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[96] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].
[97] M. Palmer. Clinical Trials: A Practical Approach , 1985 .
[98] R. Horton,et al. [Uniform requirements for manuscripts submitted to biomedical journals. The International Committee of Medical Journal Editors]. , 1997, Revista de sanidad e higiene publica.
[99] C. Fowler,et al. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. , 2005, Health technology assessment.
[100] D. Moher,et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.
[101] J. Tukey. Some thoughts on clinical trials, especially problems of multiplicity. , 1977, Science.
[102] T C Chalmers,et al. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.
[103] K. Khan,et al. Logistic regression models in obstetrics and gynecology literature. , 1999, Obstetrics and gynecology.
[104] Isabelle Boutron,et al. Reporting of safety results in published reports of randomized controlled trials. , 2009, Archives of internal medicine.
[105] S. Pocock,et al. When to stop a clinical trial. , 1992, BMJ.
[106] C Cates,et al. Confidence intervals for the number needed to treat , 1999 .
[107] G H Guyatt,et al. Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. , 1998, JAMA.
[108] Lisa Bero,et al. Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others , 2007, PLoS medicine.
[109] Paul Gallo,et al. PhRMA Working Group on Adaptive Designs: Introduction to the Full White Paper , 2006 .
[110] S. Hollis,et al. What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.
[111] Douglas G. Altman,et al. Statistics with confidence: Confidence intervals and statistical guidelines . , 1990 .
[112] K. Lee,et al. Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? , 2000, American heart journal.
[113] G. Enas,et al. Baseline Comparability in Clinical Trials: Prevention of “Poststudy Anxiety” , 1990 .
[114] Stephen Senn,et al. Cross-over trials in clinical research , 1993 .
[115] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[116] R. Kruse,et al. Intention-to-treat analysis: who is in? Who is out? , 2002, The Journal of family practice.
[117] J. Lachin. Properties of simple randomization in clinical trials. , 1988, Controlled clinical trials.
[118] D. Spiegelhalter,et al. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study , 2004, Clinical trials.
[119] Alan Cantor,et al. The uncertainty principle and industry-sponsored research , 2000, The Lancet.
[120] K. Dickersin. How important is publication bias? A synthesis of available data. , 1997, AIDS education and prevention : official publication of the International Society for AIDS Education.
[121] R. Horton,et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. , 2005, Saudi medical journal.
[122] J. Hall,et al. Misuse of statistical methods in the Australasian surgical literature. , 1982, The Australian and New Zealand journal of surgery.
[123] Douglas G Altman,et al. Missing outcomes in randomized trials: addressing the dilemma , 2009, Open medicine : a peer-reviewed, independent, open-access journal.
[124] D Moher,et al. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.
[125] A. Culyer,et al. Community provision of hearing aids and related audiology services. , 2000, Health technology assessment.
[126] C. Junker. Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German. , 1998, JAMA.
[127] S. Pocock,et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.
[128] D. DeMets,et al. The agonising negative trend in monitoring of clinical trials , 1999, The Lancet.
[129] John P A Ioannidis,et al. Limitations are not properly acknowledged in the scientific literature. , 2007, Journal of clinical epidemiology.
[130] Frederick Mosteller,et al. Reporting on methods in clinical trials. , 1982, The New England journal of medicine.
[131] A. Astrup,et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2009, The Lancet.
[132] B. Koes,et al. Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial , 2009, BMJ : British Medical Journal.
[133] Duff Waring,et al. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials , 2004, BMJ : British Medical Journal.
[134] J. Cuzick,et al. More on zidovudine in asymptomatic HIV infection. , 1994, The New England journal of medicine.
[135] A. Hrõbjartsson,et al. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study , 2005, BMJ : British Medical Journal.
[136] G. Guyatt,et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. , 2001, JAMA.
[137] B. Psaty,et al. Generalizability of the results of randomized trials. , 2008, Archives of internal medicine.
[138] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[139] D L Sackett,et al. An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.
[140] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[141] Sally Hopewell,et al. Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report. , 2007, Journal of the Royal Society of Medicine.
[142] M C Weinstein,et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[143] L. Wright,et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infant , 1994 .
[144] G. Guyatt,et al. Users' guides to the medical literature. , 1993, JAMA.
[145] P. Gøtzsche. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.
[146] Michael Clarke,et al. Non-random Reflections on Health Services Research , 1998, BMJ.
[147] T C Chalmers,et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. , 1978, The New England journal of medicine.
[148] P. Korenblat,et al. A randomized double-blind trial , 2003 .
[149] G. Piaggio,et al. The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial , 2003, BMC medical research methodology.
[150] R. Findling,et al. Controlled Clinical Trial of Zolpidem for the Treatment of Insomnia Associated With Attention-Deficit/ Hyperactivity Disorder in Children 6 to 17 Years of Age , 2009, Pediatrics.
[151] J. Hilden,et al. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. , 2007, International journal of epidemiology.
[152] A. Tonks,et al. A clinical trials register for Europe , 2002, BMJ : British Medical Journal.
[153] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[154] S. Senn,et al. Base Logic: Tests of Baseline Balance in Randomized Clinical Trials , 1995 .
[155] Douglas G. Altman,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[156] D G Altman,et al. Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.
[157] D G Altman,et al. Statistics Notes: Interaction 2: compare effect sizes not P values , 1996, BMJ.
[158] T C Chalmers,et al. Ascorbic acid for the common cold. A prophylactic and therapeutic trial. , 1975, JAMA.
[159] Patrick J. Kelly,et al. A Practical Comparison of Group-Sequential and Adaptive Designs , 2005, Journal of biopharmaceutical statistics.
[160] P. Holland. Statistics and Causal Inference , 1985 .
[161] M. Outzen. Splint for Base-of-Thumb Osteoarthritis: A Randomized Trial , 2010 .
[162] T. Wachs,et al. CONSORT for reporting randomised trials in journal and conference abstracts , 2008 .
[163] B. Morrey,et al. Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement , 2000, Annals of Internal Medicine.
[164] P. Gøtzsche,et al. Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis , 1995, BMJ.
[165] J. Bodfish,et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. , 1999, The New England journal of medicine.
[166] Douglas G Altman,et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.
[167] T O Jefferson,et al. Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.
[168] A. Catanzaro,et al. Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis , 2000, Annals of Internal Medicine.
[169] Isabelle Boutron,et al. Splint for Base-of-Thumb Osteoarthritis , 2009, Annals of Internal Medicine.
[170] J. Donovan,et al. Reporting on quality of life in randomised controlled trials: bibliographic study , 1998, BMJ.
[171] C D Naylor,et al. Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness? , 1992, Annals of Internal Medicine.
[172] Saravu R Narahari,et al. Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model. , 2008, Journal of alternative and complementary medicine.
[173] Jesper Nielsen,et al. Laypersons' understanding of relative risk reductions: Randomised cross-sectional study , 2008, BMC Medical Informatics Decis. Mak..
[174] D. Altman. Comparability of Randomised Groups , 1985 .
[175] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[176] S. Pocock,et al. Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.
[177] N. Black. CONSORT , 1996, The Lancet.
[178] C. Meinert. Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.
[179] The-Open-Study-Infants-Respiratory-Insufficiency-S. Early versus delayed neonatal administration of a synthetic surfactant — The judgment of OSIRIS , 1992 .
[180] L. Katz,et al. Uterine Exteriorization Compared With In Situ Repair at Cesarean Delivery: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.
[181] J. Manson,et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.
[182] C. Gluud,et al. Randomized clinical trials in Hepatology: Predictors of quality , 1999, Hepatology.
[183] C. Meinert. Masked monitoring in clinical trials--blind stupidity? , 1998, New England Journal of Medicine.
[184] M. Pittler. Systematic Reviews in Health Care: Meta‐analysis in Context , 2010 .
[185] D G Altman,et al. The scandal of poor medical research , 1994, BMJ.
[186] D. Rubin,et al. Intention‐to‐treat analysis and the goals of clinical trials , 1995, Clinical pharmacology and therapeutics.
[187] J. Tyson,et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 1994, The New England journal of medicine.
[188] Ian R White,et al. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals , 2004, Clinical trials.
[189] G. Norman,et al. Randomized controlled trials. , 2004, AJR. American journal of roentgenology.
[190] Gordon H Guyatt,et al. Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.
[191] A Oakley,et al. Assessment of generalisability in trials of health interventions: suggested framework and systematic review , 2006, BMJ : British Medical Journal.
[192] Christian Gluud,et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? , 2003, JAMA.
[193] J P Kassirer,et al. Clinical trials and meta-analysis. What do they do for us? , 1992, The New England journal of medicine.
[194] D. Rennie,et al. Stopping medical research to save money: a broken pact with researchers and patients. , 2003, JAMA.
[195] D. Rennie. CONSORT revised--improving the reporting of randomized trials. , 2001, JAMA.
[196] Holger J Schünemann,et al. Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials , 2006, Clinical orthopaedics and related research.
[197] Ezekiel Uba Nwose,et al. The Lancet Handbook of Essential Concepts in Clinical Research , 2007 .
[198] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[199] C. Adams,et al. Content and quality of 2000 controlled trials in schizophrenia over 50 years , 1998, BMJ.
[200] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[201] A. Hrõbjartsson,et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.
[202] D. Grimes,et al. Preventing IUCD‐related pelvic infection: The efficacy of prophylactic doxycycline at insertion , 1991, British journal of obstetrics and gynaecology.
[203] A. LaCroix,et al. Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults , 2000, Annals of Internal Medicine.
[204] Tom Lang,et al. How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers , 1997 .
[205] U. Haag. Technologies for Automating Randomized Treatment Assignment in Clinical Trials , 1998 .
[206] Call for Comments on a Proposal To Improve Reporting of Clinical Trials in the Biomedical Literature , 1994, Annals of Internal Medicine.
[207] N. Talley,et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. , 1996, The American journal of gastroenterology.
[208] J J Shuster,et al. Median follow-up in clinical trials. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[209] J. H. Mitchell. Medical aid to vietnam. , 1969, The Medical journal of Australia.
[210] C Weijer,et al. A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group. , 1998, Journal of clinical epidemiology.
[211] M Docherty,et al. The case for structuring the discussion of scientific papers , 1999, BMJ.
[212] S. Shapiro,et al. The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say? , 2007, Clinical trials.
[213] M. Boyle,et al. Treatment of attention-deficit/hyperactivity disorder. , 1999, Evidence report/technology assessment.
[214] J. Deeks,et al. Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial , 2000, BMJ : British Medical Journal.
[215] D. G. Altman,et al. Review of survival analyses published in cancer journals. , 1995, British Journal of Cancer.
[216] P. Gøtzsche,et al. Blinding during data analysis and writing of manuscripts. , 1996, Controlled clinical trials.
[217] D. Altman,et al. Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey , 2002, Annals of Internal Medicine.
[218] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[219] I. Leviton,et al. Registering clinical trials. , 2003, Journal of the American Medical Association (JAMA).
[220] Giuseppe Mancia,et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.
[221] J. Ioannidis,et al. Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.
[222] Guosheng Yin,et al. Fundamentals of Clinical Trials , 2012 .
[223] D. Elbourne,et al. A randomised controlled trial of care of the perineum during second stage of normal labour , 1998, British journal of obstetrics and gynaecology.
[224] Mike Clarke,et al. Standardising outcomes for clinical trials and systematic reviews , 2007, Trials.
[225] P. Rothwell,et al. Factors That Can Affect the External Validity of Randomised Controlled Trials , 2006, PLoS clinical trials.
[226] R. Horton. The rhetoric of research , 1995, BMJ.
[227] Lois Ann Colaianni,et al. Uniform Requirements for Manuscripts Submitted to Biomedical Journals , 1991, The Medical journal of Australia.
[228] D. Campbell. Factors relevant to the validity of experiments in social settings. , 1957, Psychological bulletin.
[229] S. Golder,et al. The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. , 2000, Health technology assessment.
[230] Douglas G Altman,et al. Epidemiology and reporting of randomised trials published in PubMed journals , 2005, The Lancet.
[231] T. Mills,et al. Measuring Health: A Guide to Rating Scales and Questionnaires , 2006 .
[232] S. Pocock,et al. Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.
[233] P Armitage,et al. The role of randomization in clinical trials. , 1982, Statistics in medicine.
[234] L. Sadler,et al. A randomised controlled trial and meta‐analysis of active management of labour , 2000, BJOG : an international journal of obstetrics and gynaecology.
[235] James Hartley,et al. Obtaining information accurately and quickly: are structured abstracts more efficient? , 1996, J. Inf. Sci..
[236] S. Yusuf,et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.
[237] Emmanuel Lagarde,et al. Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial , 2005, PLoS medicine.
[238] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[239] L. Rajmil. Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .
[240] K. Barnhart,et al. Multicenter Comparison of the Contraceptive Ring and Patch: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.
[241] Philippe Ravaud,et al. Reporting of sample size calculation in randomised controlled trials: review , 2009, BMJ : British Medical Journal.
[242] Asbjørn Hróbjartsson,et al. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors , 2006, Clinical trials.
[243] S. Pocock. Statistical Aspects of Clinical Trial Design , 1982 .
[244] D. Tate,et al. Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. , 2003, JAMA.
[245] C. Adams,et al. Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia , 2000, British Journal of Psychiatry.
[246] D G Altman,et al. Statistics notes: Interaction 3: How to examine heterogeneity , 1996 .
[247] R. Anderson,et al. Impact and Process Evaluation of Integrated Community and Clinic-Based HIV-1 Control: A Cluster-Randomised Trial in Eastern Zimbabwe , 2007, PLoS medicine.
[248] G D Murray,et al. Promoting good research practice , 2000, Statistical methods in medical research.
[249] J. Ioannidis,et al. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. , 2001, JAMA.
[250] V. Barbour,et al. The impact of open access upon public health. , 2006, Bulletin of the World Health Organization.
[251] F. McAlister. Applying the Results of Systematic Reviews at the Bedside , 2008 .
[252] B. Djulbegovic,et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.
[253] I. McDowell,et al. Measuring health: A guide to rating scales and questionnaires, 3rd ed. , 2006 .
[254] S. Bolton. Independence and Statistical Inference in Clinical Trial Designs: A Tutorial Review , 1998, Journal of clinical pharmacology.
[255] J H Ellenberg,et al. Analysis of clinical trials by treatment actually received: is it really an option? , 1991, Statistics in medicine.
[256] J. Ioannidis,et al. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.
[257] ISIS-1 Collaborative Group. RANDOMISED TRIAL OF INTRAVENOUS ATENOLOL AMONG 16 027 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-1 , 1986, The Lancet.
[258] C. Meinert,et al. Treatment effects monitoring committees and early stopping in large clinical trials , 2004, Clinical trials.
[259] Peter C Gøtzsche,et al. Believability of relative risks and odds ratios in abstracts: cross sectional study , 2006, BMJ : British Medical Journal.
[260] Gordon H Guyatt,et al. In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter? , 2008, PLoS medicine.
[261] R. Ness-Abramof. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2010 .
[262] P. Bower,et al. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. , 2005, Health technology assessment.
[263] H. Williams,et al. How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.
[264] T. Lang,et al. How to Report Statistics in Medicine: Annotated Guidelines for Authors , 1997 .
[265] J. PérezMartín,et al. [International Committee of Medical Journal Editors]. , 2008, Revista alergia Mexico.
[266] T C Chalmers,et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.
[267] D. Henson,et al. The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma. , 2005, Health technology assessment.
[268] U Grouven,et al. Logistic regression models used in medical research are poorly presented , 1996, BMJ.
[269] N. Nagelkerke,et al. Estimating treatment effects in randomized clinical trials in the presence of non-compliance. , 2000, Statistics in medicine.
[270] M. Staun,et al. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. , 2000, Gastroenterology.
[271] E. Verhagen,et al. Effect of unsupervised home based proprioceptive training on recurrences of ankle sprain: randomised controlled trial , 2009, BMJ : British Medical Journal.
[272] M. Manary,et al. Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial , 2009, BMJ : British Medical Journal.
[273] Sangeeta Mehta,et al. Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.
[274] D. Sackett,et al. The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.
[275] C. R.J.,et al. Statistics with Confidence (2nd ed.) , 2003 .
[276] W. Elliott. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2009 .
[277] V. Torri,et al. Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. , 1989, JAMA.
[278] G. Guyatt,et al. In the dark: the reporting of blinding status in randomized controlled trials. , 2002, Journal of clinical epidemiology.
[279] Kenneth F Schulz,et al. Randomised trials, human nature, and reporting guidelines , 1996, The Lancet.
[280] F. Davidoff. News from the International Committee of Medical Journal Editors , 2000, Annals of Internal Medicine.
[281] David Moher,et al. Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement , 2006, Annals of Internal Medicine.
[282] D. Moher,et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.
[283] R. Collins,et al. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials , 2001, The Lancet.
[284] Å. Westin,et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety , 2000, BMJ : British Medical Journal.
[285] J. Hall,et al. Methodologic standards in surgical trials. , 1996, Surgery.
[286] D. Sackett. Turning a blind eye:Why we don't test for blindness at the end of our trials , 2004, BMJ : British Medical Journal.
[287] S. Pocock,et al. Trials stopped early: too good to be true? , 1999, The Lancet.
[288] A J Sutton,et al. Publication and related biases. , 2000, Health technology assessment.
[289] Peter Fonagy,et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data , 2004, The Lancet.
[290] A. Colevas,et al. Adverse event reporting in publications compared with sponsor database for cancer clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[291] R. Simes. Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[292] J L Hutton,et al. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. , 2000, Statistics in medicine.
[293] B L Humphreys,et al. Structured abstracts in MEDLINE, 1989-1991. , 1995, Bulletin of the Medical Library Association.
[294] M Egger,et al. The causes and effects of socio-demographic exclusions from clinical trials. , 2005, Health technology assessment.
[295] Leah G Ward,et al. Accuracy of Abstracts for Original Research Articles in Pharmacy Journals , 2004, The Annals of pharmacotherapy.
[296] N. Talley,et al. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. , 1996, The American journal of gastroenterology.
[297] M. Gardner,et al. More informative abstracts revisited. , 1990, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.
[298] J. Karlawish,et al. The continuing unethical conduct of underpowered clinical trials. , 2002, JAMA.
[299] Douglas G Altman,et al. Analysis and reporting of factorial trials: a systematic review. , 2003, JAMA.
[300] C. Weijer,et al. Reporting the study populations of clinical trials. Clear transmission or static on the line? , 2000, Journal of clinical epidemiology.
[301] P. Gøtzsche. Reference bias in reports of drug trials. , 1987, British medical journal.
[302] T. Treasure,et al. Minimisation: the platinum standard for trials? , 1998, BMJ.
[303] M Egger,et al. Value of flow diagrams in reports of randomized controlled trials. , 2001, JAMA.
[304] John Hoey,et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors , 2005, The Lancet.
[305] Brian Hutton,et al. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? , 2005, Clinical trials.
[306] K. Papp,et al. Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study , 2008, The Lancet.
[307] Sally Hopewell,et al. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.
[308] P. Mease,et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.
[309] D. Altman,et al. CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.
[310] Sergio Sismondo,et al. Pharmaceutical company funding and its consequences: a qualitative systematic review. , 2008, Contemporary clinical trials.
[311] J C Bailar,et al. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. , 1988, Annals of internal medicine.
[312] D. Ashby,et al. Randomized controlled trials in cystic fibrosis (1966–1997) categorized by time, design, and intervention , 2000, Pediatric pulmonology.
[313] G. Sas. Treatment for haemophilia by calendar in Hungary , 1997, BMJ.
[314] O. Dalesio,et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.
[315] J Chilcott,et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. , 2003, Health technology assessment.
[316] Lain Chalmers. Assembling Comparison Groups to Assess the Effects of Health care * , 1997, Journal of the Royal Society of Medicine.
[317] Milton C. Weinstein,et al. Recommendations for Reporting Cost-effectiveness Analyses , 1996 .
[318] Laurence H. Baker,et al. Clinical Trials: Design, Conduct, and Analysis , 1987 .
[319] R M Pitkin,et al. Accuracy of data in abstracts of published research articles. , 1999, JAMA.
[320] Jon Smith. Crossover Trials in Clinical Research: By Stephen Senn. John Wiley & Sons Ltd., 1993. pp. xv + 266. £24.95. ISBN 0-471-93493-3 , 1993 .
[321] M. Buyse. Interim analyses, stopping rules and data monitoring in clinical trials in Europe. , 1993, Statistics in medicine.
[322] D G Altman,et al. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. , 1994, JAMA.
[323] T. Kiviluoto,et al. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis , 1998, The Lancet.
[324] Brian Hutton,et al. Does analysis using “last observation carried forward” introduce bias in dementia research? , 2008, Canadian Medical Association Journal.
[325] M. Egger,et al. Who benefits from medical interventions? , 1994, BMJ.
[326] Steve McDonald,et al. Development of the Cochrane Collaboration’s Central Register of Controlled Clinical Trials , 2002, Evaluation & the health professions.
[327] M. Gardner,et al. Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.
[328] M. Gardner,et al. Statistical guidelines for contributors to medical journals. , 1983, British medical journal.
[329] R. Ferrari,et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[330] Douglas G Altman,et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.
[331] S. Carley,et al. An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb , 2000, BMJ : British Medical Journal.
[332] G. Leung,et al. Quality of Reporting of Key Methodological Items of Randomized Controlled Trials in Clinical Ophthalmic Journals , 2007, Ophthalmic epidemiology.
[333] M. Gold,et al. Panel on cost-effectiveness in health and medicine. , 1996, Medical care.
[334] A. Mantingh,et al. Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term , 1997, The Lancet.
[335] D. G. Altman,et al. Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.
[336] R. Buchbinder,et al. Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial , 2006, BMC musculoskeletal disorders.
[337] Dwight Lemon,et al. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .
[338] C. Gamble,et al. Identification and impact of outcome selection bias in meta‐analysis , 2005, Statistics in medicine.
[339] D. Moher,et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews , 1996, The Lancet.
[340] Phil Barton,et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial , 2000, The Lancet.